Gαi2-mediated protection from ischaemic injury is modulated by endogenous RGS proteins in the mouse heart

Cardiovascular Research

Volumn 91, Issue 1, 2011, Pages 45-52

  Waterson, Rachael E ^a   Thompson, Corbin G ^a   Mabe, Nathaniel W ^a   Kaur, Kuljeet ^b   Talbot, Jeffery N ^a   Neubig, Richard R ^b   Rorabaugh, Boyd R ^a  

^a OHIO NORTHERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Gi2; Ischaemia reperfusion injury; Ischaemic preconditioning; Regulator of G protein signalling (RGS)

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 5 HYDROXYDECANOIC ACID; CLAMIKALANT; G PROTEIN COUPLED RECEPTOR; PROTEIN KINASE B; RECEPTOR SUBUNIT; RGS PROTEIN; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HEART CONTRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HETEROZYGOSITY; HOMOZYGOSITY; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENOTYPE; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; KATP CHANNELS; LEAST-SQUARES ANALYSIS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PERFUSION; PHENOTYPE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RGS PROTEINS; SIGNAL TRANSDUCTION;

EID: 79958835285     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr054     Document Type: Article

References (32)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136. (Pubitemid 17174962)
2. Cochrane J, Williams BT, Banerjee A, Harken AH, Burke TJ, Cairns CB et al. Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Ren Fail 1999;21:135-145. (Pubitemid 29143814)
3. Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, Shimabukuro T et al. Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996;128:251-258. (Pubitemid 27506936)
4. Liu Y, Kato H, Nakata N, Kogure K. Protection of rat hippocampus against ischemic neuronal damage by pretreatment with sublethal ischemia. Brain Res 1992;586: 121-124.
5. Zahir KS, Syed SA, Zink JR, Restifo RJ, Thomson JG. Ischemic preconditioning improves the survival of skin and myocutaneous flaps in a rat model. Plast Reconstr Surg 1998;102:140-150.
6. Eisen A, Fisman EZ, Rubenfire M, Freimark D, McKechnie R, Tenenbaum R et al. Ischemic preconditioning: nearly two decades of research. A comprehensive review. Atherosclerosis 2004;172:201-210. (Pubitemid 38167530)
7. Ye C, Sowell MO, Vassilev PM, Milstone DS, Mortensen RM. Galpha(i2), Galpha(i3)and Galpha(o) are all required for normal muscarinic inhibition of the cardiac calcium channels in nodal/atrial-like cultured cardiocytes. J Mol Cell Cardiol 1999;31:1771-1781. (Pubitemid 29414595)
8. Riddle EL, Schwartzman RA, Bond M, Insel PA. Multi-tasking RGS proteins in the heart: the next therapeutic target? Circ Res 2005;96:401-411. (Pubitemid 40354533)
9. Huang X, Fu Y, Charbeneau RA, Saunders TL, Taylor DK, Hankenson KD et al. Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele. Mol Cell Biol 2006;26:6870-6879. (Pubitemid 44387636)
10. Lan KL, Sarvazvan NA, Taussig R, Mackenzie RG, DiBello PR, Dohlman HG et al. A point mutation in Gao and Gai1 blocks interaction with regulator of G protein signaling proteins. J Biol Chem 1998;273:1794-1797.
11. Fu Y, Huang X, Piao L, Lopatin AN, Neubig RR. Endogenous RGS proteins modulate SA and AV nodal functions in isolated heart: implications for sick sinus syndrome and AV block. Am J Physiol Heart Circ Physiol 2007;292:H2532-H2539. (Pubitemid 47084638)
12. Fu Y, Huang X, Zhong H, Mortensen RM, D'Alecy LG, Neubig RR. Endogenous RGS proteins and Galpha subtypes differentially control muscarinic and adenosinemediated chronotropic effects. Circ Res 2006;98:659-666.
13. O'Connell TD, Rodrigo MC, Simpson PC. Isolation and culture of adult mouse cardiac myocytes. Methods Mol Biol 2007;357:271-296. (Pubitemid 350183253)
14. Motulsky HJ, Neubig RR. Analyzing binding data. In: Current Protocols in Neuroscience. Hoboken, NJ: John Wiley & Sons, Inc, 2010. p7.5.1-7.5.65
15. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 2005;15:69-75. (Pubitemid 40693390)
16. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases. Am J Physiol Heart Circ Physiol 2005;288:H971-H976. (Pubitemid 40139686)
17. Wynne AM, Mocanu MM, Yellon DM. Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for prosurival kinases PI3K and P42/P44 MAPK. J Cardiovas Pharmacol 2005;46:817-822. (Pubitemid 44378255)
18. Bell RM, Clark JE, Hearse DJ, Shattock MJ. Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: characterisation in the bi-phasic profile of early and late preconditioning. Cardiovasc Res 2007;73:153-163. (Pubitemid 44940781)
19. Oldenturg O, Cohen MV, Yellon DM, Downey JM. Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc Res 2002;55:429-437. (Pubitemid 34874938)
20. Murphy E, Steenbergen C. Preconditioning: the mitochondrial connection. Ann Rev Physiol 2007;69:51-67. (Pubitemid 46457635)
21. Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M et al. Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 2002;109:509-516. (Pubitemid 34171782)
22. DeGeorge BR Jr, Gao E, Boucher M, Vinge LE, Martini JS, Raake PW et al. Targeted inhibition of cardiomyocyte Gi signaling enhances susceptibility to apoptotic cell death in response to ischemic stress. Circulation 2008;117:1378-1387. (Pubitemid 351501491)
23. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 2000;62:79-109. (Pubitemid 30618257)
24. Talbot JN, Jutkiewicz EM, Graves SM, Clemans CF, Nicol MR, Mortensen RM et al. RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects. Proc Natl Acad Sci USA 2010;107:11086-11091.
25. Juhaszova M, Zoroy DB, Yaniv Y, Nuss HB, Wang S, Sollot SJ. Role of glycogen synthase kinase-3 beta in cardioprotection. Circ Res 2009;104:1240-1252.
26. Stein AB, Tang XL, Guo Y, Xuan YT, Dawn B, Bolli R. Delayed adaptation of the heart to stress: late preconditioning. Stroke 2004;35:2676-2679. (Pubitemid 39458366)
27. Chen DM, Xiao L, Cai X, Zeng R, Zhu XZ. Involvement of multitargets in paeoniflorin-induced preconditioning. J Pharmacol Exp Ther 2006;319:165-180. (Pubitemid 44455121)
28. Shelat PB, Coulibaly AP, Wang Q, Sun AY, Sun GY, Simonyi A. Ischemia-induced increase in RGS7 mRNA expression in gerbil hippocampus. Neurosci Lett 2006;403: 157-161. (Pubitemid 43963255)
29. Cervia D, Martini D, Ristori C, Catalani E, Timperio AM, Bagnoli P et al. Modulation of the neuronal response to ischaemia by somatostatin analogues in wild-type and knock-out mouse retinas. J Neurochem 2008;106:2224-2235.
30. Bodenstein J, Sunahara RK, Neubig RR. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells. Mol Pharmacol 2007;71:1040-1050. (Pubitemid 46457008)
31. Blazer LL, Roman DL, Chung A, Larsen MJ, Greedy BM, Husbands SM et al. Reversible allosteric small-molecule inhibitors of regulator of G protein signaling proteins. Mol Pharmacol 2010;78:524-533.
32. Roman DL, Blazer LL, Monroy CA, Neubig RR. Allosteric inhibition of the regulator of G protein signaling Ga protein-protein interaction by CCG-4986. Mol Pharmacol 2010;78:360-365.